跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 42,128 条关于
“TP53-mutated acute myeloid leukemia”
全部
42,128
临床试验
36,311
药物
542
机构
43
资讯
5,232
17天前
Leukemia Research Foundation funds UC study targeting RhoA in TP53-mutated AML
9个月前
FDA Approves Ziftomenib, First-in-Class Targeted Therapy for NPM1-Mutated Acute Myeloid Leukemia
4年前
FDA Approves Ivosidenib Plus Azacitidine for IDH1-Mutated Acute Myeloid Leukemia
3年前
FDA Approves Olutasidenib for Relapsed or Refractory AML with IDH1 Mutation
去年
Revumenib Shows Promise in Relapsed/Refractory NPM1-Mutated AML
去年
Diabetes Drug Metformin Shows Promise in Preventing Acute Myeloid Leukemia
3年前
Revumenib Shows Breakthrough Results in Advanced Acute Myeloid Leukemia Trial
上个月
Russia Begins Bioequivalence Trials of Generic Gilteritinib for FLT3-Mutated Acute Myeloid Leukaemia
9个月前
Forskolin Shows Dual Mechanism Against Aggressive KMT2A-Rearranged Acute Myeloid Leukemia
去年
FDA Grants Fast Track Designation to HC-7366 for Relapsed/Refractory AML
第 1 页，共 524 页
上一页
下一页
